Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOMILNACIPRAN vs LEVONORGESTREL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOMILNACIPRAN vs LEVONORGESTREL: Safety Overview

Metric LEVOMILNACIPRAN LEVONORGESTREL
Total FAERS Reports 1,378 115,347
Deaths Reported 382 142
Death Rate 27.7% 0.1%
Hospitalizations 378 6,322
Average Patient Age 46.4 yrs 31.1 yrs
% Female Patients 80.2% 99.5%
FDA Approval Date Feb 4, 2019 Aug 15, 1996
Manufacturer Allergan, Inc. Bayer HealthCare Pharmaceuticals Inc.
Route ORAL INTRAUTERINE
Marketing Status Prescription Discontinued